FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS
Described herein is a gene construct comprising a nucleotide sequence encoding a fibroblast growth factor 21 (FGF21), for use in the treatment and/or prevention of a central nervous system (CNS) disorder or disease, or a condition associated therewith. L'invention concerne une construction géni...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GRASS COSTA, Ignasi JAMBRINA PALLARES, Claudia BOSCH TUBERT, Maria Fatima JIMENEZ CENZANO, Veronica FRAILE, Victor Sacristan ELIAS PUIGDOMENECH, Ivet |
| description | Described herein is a gene construct comprising a nucleotide sequence encoding a fibroblast growth factor 21 (FGF21), for use in the treatment and/or prevention of a central nervous system (CNS) disorder or disease, or a condition associated therewith.
L'invention concerne une construction génique comprenant une séquence nucléotidique codant pour un facteur de croissance des fibroblastes 21 (FGF21), destiné à être utilisé dans le traitement et/ou la prévention d'un trouble ou d'une maladie du système nerveux central (SNC), ou un état associé à celui-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021239815A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021239815A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021239815A13</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEuDqK-w4GLDoJJEXRM00tSqIlcrpZOpUicRAv1_dHBB3D6h--fZ42pCgpFrSKDpdCyA6M0BwIpYGOskWILFj0COyR16cB8TaNnUjV4pGtoIsQuMp6hrGKgEikus9l9eExp9esiWxtk7XZpfPVpGodbeqZ33wa5l0Lmp6M4KJH_d30A1hMw7A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS</title><source>esp@cenet</source><creator>GRASS COSTA, Ignasi ; JAMBRINA PALLARES, Claudia ; BOSCH TUBERT, Maria Fatima ; JIMENEZ CENZANO, Veronica ; FRAILE, Victor Sacristan ; ELIAS PUIGDOMENECH, Ivet</creator><creatorcontrib>GRASS COSTA, Ignasi ; JAMBRINA PALLARES, Claudia ; BOSCH TUBERT, Maria Fatima ; JIMENEZ CENZANO, Veronica ; FRAILE, Victor Sacristan ; ELIAS PUIGDOMENECH, Ivet</creatorcontrib><description>Described herein is a gene construct comprising a nucleotide sequence encoding a fibroblast growth factor 21 (FGF21), for use in the treatment and/or prevention of a central nervous system (CNS) disorder or disease, or a condition associated therewith.
L'invention concerne une construction génique comprenant une séquence nucléotidique codant pour un facteur de croissance des fibroblastes 21 (FGF21), destiné à être utilisé dans le traitement et/ou la prévention d'un trouble ou d'une maladie du système nerveux central (SNC), ou un état associé à celui-ci.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211202&DB=EPODOC&CC=WO&NR=2021239815A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211202&DB=EPODOC&CC=WO&NR=2021239815A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GRASS COSTA, Ignasi</creatorcontrib><creatorcontrib>JAMBRINA PALLARES, Claudia</creatorcontrib><creatorcontrib>BOSCH TUBERT, Maria Fatima</creatorcontrib><creatorcontrib>JIMENEZ CENZANO, Veronica</creatorcontrib><creatorcontrib>FRAILE, Victor Sacristan</creatorcontrib><creatorcontrib>ELIAS PUIGDOMENECH, Ivet</creatorcontrib><title>FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS</title><description>Described herein is a gene construct comprising a nucleotide sequence encoding a fibroblast growth factor 21 (FGF21), for use in the treatment and/or prevention of a central nervous system (CNS) disorder or disease, or a condition associated therewith.
L'invention concerne une construction génique comprenant une séquence nucléotidique codant pour un facteur de croissance des fibroblastes 21 (FGF21), destiné à être utilisé dans le traitement et/ou la prévention d'un trouble ou d'une maladie du système nerveux central (SNC), ou un état associé à celui-ci.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEuDqK-w4GLDoJJEXRM00tSqIlcrpZOpUicRAv1_dHBB3D6h--fZ42pCgpFrSKDpdCyA6M0BwIpYGOskWILFj0COyR16cB8TaNnUjV4pGtoIsQuMp6hrGKgEikus9l9eExp9esiWxtk7XZpfPVpGodbeqZ33wa5l0Lmp6M4KJH_d30A1hMw7A</recordid><startdate>20211202</startdate><enddate>20211202</enddate><creator>GRASS COSTA, Ignasi</creator><creator>JAMBRINA PALLARES, Claudia</creator><creator>BOSCH TUBERT, Maria Fatima</creator><creator>JIMENEZ CENZANO, Veronica</creator><creator>FRAILE, Victor Sacristan</creator><creator>ELIAS PUIGDOMENECH, Ivet</creator><scope>EVB</scope></search><sort><creationdate>20211202</creationdate><title>FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS</title><author>GRASS COSTA, Ignasi ; JAMBRINA PALLARES, Claudia ; BOSCH TUBERT, Maria Fatima ; JIMENEZ CENZANO, Veronica ; FRAILE, Victor Sacristan ; ELIAS PUIGDOMENECH, Ivet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021239815A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>GRASS COSTA, Ignasi</creatorcontrib><creatorcontrib>JAMBRINA PALLARES, Claudia</creatorcontrib><creatorcontrib>BOSCH TUBERT, Maria Fatima</creatorcontrib><creatorcontrib>JIMENEZ CENZANO, Veronica</creatorcontrib><creatorcontrib>FRAILE, Victor Sacristan</creatorcontrib><creatorcontrib>ELIAS PUIGDOMENECH, Ivet</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GRASS COSTA, Ignasi</au><au>JAMBRINA PALLARES, Claudia</au><au>BOSCH TUBERT, Maria Fatima</au><au>JIMENEZ CENZANO, Veronica</au><au>FRAILE, Victor Sacristan</au><au>ELIAS PUIGDOMENECH, Ivet</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS</title><date>2021-12-02</date><risdate>2021</risdate><abstract>Described herein is a gene construct comprising a nucleotide sequence encoding a fibroblast growth factor 21 (FGF21), for use in the treatment and/or prevention of a central nervous system (CNS) disorder or disease, or a condition associated therewith.
L'invention concerne une construction génique comprenant une séquence nucléotidique codant pour un facteur de croissance des fibroblastes 21 (FGF21), destiné à être utilisé dans le traitement et/ou la prévention d'un trouble ou d'une maladie du système nerveux central (SNC), ou un état associé à celui-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2021239815A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A26%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GRASS%20COSTA,%20Ignasi&rft.date=2021-12-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021239815A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |